Press Releases for ONXX

Press Releases
RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on MGM, MDT, MO, MENT, ONXX and WFMI
Biotech Cools Off in August But Capital Markets Remain Positive
Biotech Cools Off in August But Capital Markets Remain Positive
Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
Onyx Pharmaceuticals to Present at the 29th Annual Canaccord Adams Global Growth Conference
Onyx Pharmaceuticals Announces Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
Onyx Pharmaceuticals Announces Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
Onyx Pharmaceuticals Reports Second Quarter 2009 Financial Results; Nexavar Global Net Sales Reach $201 Million, 19% Increase Over Second Quarter 2008
Onyx Pharmaceuticals Announces Second Quarter 2009 Financial Results Teleconference and Webcast
StockPreacher.com Issues Trading Outlook for Onyx Pharmaceuticals Inc. (ONXX)
Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
BenchmarkJournal.Com Free Analyst Review for BPFH, CBSH, ONXX, EWBC, CPSL and RNWK
Onyx Pharmaceuticals to Present at the Goldman Sachs 30th Annual Global Healthcare Conference
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Onyx Pharmaceuticals Files Complaint Against Bayer Corporation
Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting
Onyx Pharmaceuticals to Present at the Deutsche Bank 34th Annual Health Care Conference
Ardea Biosciences Reports Recent Accomplishments and First Quarter 2009 Financial Results
Onyx Pharmaceuticals Reports First Quarter 2009 Financial Results
Onyx Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
Onyx Pharmaceuticals Announces First Quarter 2009 Financial Results Teleconference and Webcast
Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar
Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint
AnalystChoice.Com Free CFA Opinion on KCI, FAST, MYGN and ONXX
Quarterly Changes to the NASDAQ Q-50 Index
Onyx Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
S*BIO Receives BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award
Onyx Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
Zacks Analyst Blog Highlights: JPMorgan Chase & Co., Citigroup, Bank of America, Onyx Pharmaceuticals, Inc. And Einstein Noah Restaurant Group, Inc.
Zacks Bull and Bear of the Day Highlights: Onyx Pharma, Navigant Consulting, Bristol Myers, Biogen Idec and Strayer Education
Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Teleconference and Webcast
Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO
Onyx Pharmaceuticals to Present at the 27th Annual JPMorgan Healthcare Conference
Onyx Pharmaceuticals Names Matthew K. Fust Executive Vice President and Chief Financial Officer
Zacks Bull and Bear of the Day Highlights: Tw Telecom, AutoNation, TDS, Iron Mountain and Onyx Pharmaceuticals
Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results
Onyx Pharmaceuticals to Present at the 2008 Credit Suisse Health Care Conference
New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer
Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference and Webcast
Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors
Zacks Analyst Blog Highlights: Schlumberger Ltd., Amylin Pharmaceuticals, Inc., Eli Lilly & Co., Onyx Pharmaceuticals, Inc. And Diageo Plc.
Onyx Pharmaceuticals to Present at UBS Global Life Sciences Conference
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Onyx Pharmaceuticals Names Juergen Lasowski, Ph.D. as Senior Vice President of Corporate Development
Zacks Bull and Bear of the Day Highlights: Onyx Pharmaceuticals, National City, Amdocs, Citi Trends and Deutsche Bank
Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
Onyx Pharmaceuticals Announces Second Quarter 2008 Financial Results Teleconference and Webcast
Nexavar Approved for Liver Cancer in China
The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
Onyx Pharmaceuticals to Present at Goldman Sachs 29th Annual Global Healthcare Conference
New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study - May 27 2008 12:55AM
Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting - May 27 2008 12:55AM
Onyx Pharmaceuticals to Present at Bank of America Health Care Conference - Jun 2 2008 12:51AM
Onyx Pharmaceuticals Reports 2008 First Quarter Results - Jun 2 2008 12:51AM
Major League Baseball Hall of Famer Don Sutton Helps Kidney Cancer Patients Stay In The Game(TM) - Jun 2 2008 12:51AM
Onyx Pharmaceuticals Announces First Quarter 2008 Financial Results Teleconference and Webcast
Onyx Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference